Tech giant Samsung has teamed up with decentralized science (DeSci) and healthcare AI protocol Galeon to supply AI training data from its ultrasound devices.
In a Tuesday announcement to Cointelegraph, Samsung revealed it will link its ultrasound technology with Galeon’s electronic health record (EHR) platform. Galeon CEO Loïc Brotons shared with Cointelegraph that the EHR is currently operational in 18 linked hospitals, including facilities in France such as Rouen University Hospital, Caen University Hospital, Toulon Hospital, and Sud Francilien Hospital.
Both Samsung and Galeon stated this initiative aims to enhance medical data accessibility while prioritizing privacy. Brotons clarified that the data itself isn’t stored on-chain; only the AI algorithm functions on-chain “with full traceability of how the algorithm is operating.” He emphasized that all data is anonymized prior to training to comply with privacy regulations.
This partnership enables healthcare providers to develop AI models without centralizing patient information. Each hospital or institution maintains control over its data while benefiting from collaborative algorithm training.
Brotons informed Cointelegraph that this method of medical AI training is already making a difference. He noted that the company has created an automatic billing AI for medical services, an AI that summarizes consultations, and is developing its own speech-to-text AI.
Related: Blockchain and AI can enable advanced personalization in healthcare
Decentralized science takes on medicine
The healthcare sector has become one of the most vibrant areas in decentralized science. Alex Dobrin, awareness steward at VitaDAO—a decentralized collective focused on extending human lifespans—told Cointelegraph that the time and financial demands of drug development prompt individuals to take action independently.
In May, DeSci decentralized autonomous organization HydraDAO claimed that one of its research endeavors allowed “rats who had their spines fully transected” to walk again within five days. This news seems to be attracting investor attention.
Related: Decentralized science meets AI — legacy institutions aren’t ready
Investors show interest in DeSci
The DeSci platform Bio Protocol secured investment from various backers, including Maelstrom Fund and Animoca Brands, totaling $6.9 million in a funding round earlier this month. This followed an investment from Binance Labs, the venture capital arm of the cryptocurrency exchange, in late 2024.
Data is pivotal for many of these initiatives, with DeSci platforms now vying to acquire genetic data from the defunct DNA testing service 23andMe.
Magazine: Memecoin degeneracy is funding groundbreaking anti-aging research
